This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, Y. Articles by Wu, X. Search for Related Content PubMed PubMed Citation Articles by Zhu, Y. Articles by Wu, X.

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility¹

Departments of Epidemiology [Y. Z., M. R. S., L. L., X. W.] and Molecular Therapeutics [G. B. M.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Extracellular matrix-degrading matrix metalloproteinase-1 (MMP-1) is one of the interstitial collagenases likely to be involved in tumor invasion and metastasis. MMP-1 may also contribute to tumor initiation and development by altering the cellular microenvironment that facilitates tumor formation. Recent studies have found that overexpression of MMP-1 is associated with the initial stages of cancer development in addition to promoting cellular invasion; however, preexisting oncogenic mutations or chemical carcinogens are required to initiate tumorigenesis as well. There is a single nucleotide polymorphism located in the promoter region of MMP-1 that partially regulates gene expression. The 2G/2G genotype enhances transcriptional activity and may be associated with an increased lung cancer risk. Using a case-control study, we tested the hypotheses that (a) individuals with the 2G/2G genotype may be at an increased risk for lung cancer; and (b) the risk should be greatly elevated in smoking individuals. PCR-RFLP was used to determine the MMP-1 genotypes in 456 lung-cancer cases and 451 frequency-matched controls of Caucasian ethnicity. Overall, there was a significant association between the 2G/2G genotype and lung cancer risk [odds ratio (OR), 1.76; 95% confidence interval (CI), 1.29–2.39]. In current smokers, the lung cancer risk associated with the 2G/2G genotype was significantly elevated (OR, 3 .16; 95% CI, 1.87–5.35). However, this association was less evident in former smokers (OR, 1.23; 95% CI, 0.81–1.87) and absent in never smokers (OR, 1.09; 95% CI, 0.31–3.91). Similarly, this risk was more evident in heavy smokers (OR, 2.55; 95% CI, 1.61–4.03) than in light smokers (OR, 1.40; 95% CI, 0.84–2.32). Interestingly, men were observed to have a 2.15-fold increased lung cancer risk (OR, 2.15; 95% CI, 1.42–3.26) compared with women (OR, 1.34; 95% CI, 0.84–2.15). Furthermore, subjects with 2G/2G genotype developed lung cancer earlier (60.94 ± 0.64 years old) than patients with 1G/1G and 1G/2G genotypes (62.91 ± 0.59 years old; P = 0.024). Our data demonstrate that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers. To our knowledge, these results report the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.

This article has been cited by other articles:

				B. Peng, L. Cao, W. Wang, L. Xian, D. Jiang, J. Zhao, Z. Zhang, X. Wang, and L. Yu Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies Mutagenesis, October 20, 2009; (2009) gep041v1. [Abstract] [Full Text] [PDF]

				P. A. Bradbury, R. Zhai, J. Hopkins, M. H. Kulke, R. S. Heist, S. Singh, W. Zhou, C. Ma, W. Xu, K. Asomaning, et al. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis Carcinogenesis, May 1, 2009; 30(5): 793 - 798. [Abstract] [Full Text] [PDF]

				B. A. Mercer, A. M. Wallace, C. E. Brinckerhoff, and J. M. D'Armiento Identification of a Cigarette Smoke-Responsive Region in the Distal MMP-1 Promoter Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 4 - 12. [Abstract] [Full Text] [PDF]

				W. Sauter, A. Rosenberger, L. Beckmann, S. Kropp, K. Mittelstrass, M. Timofeeva, G. Wolke, A. Steinwachs, D. Scheiner, E. Meese, et al. Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1127 - 1135. [Abstract] [Full Text] [PDF]

				J. Decock, J.-R. Long, R. C. Laxton, X.-O. Shu, C. Hodgkinson, W. Hendrickx, E. G. Pearce, Y.-T. Gao, A. C. Pereira, R. Paridaens, et al. Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis Cancer Res., November 1, 2007; 67(21): 10214 - 10221. [Abstract] [Full Text] [PDF]

				W. K. Steagall, C. G. Glasgow, O. M. Hathaway, N. A. Avila, A. M. Taveira-DaSilva, A. Rabel, M. P. Stylianou, J.-P. Lin, X. Chen, and J. Moss Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L800 - L808. [Abstract] [Full Text] [PDF]

				L. Milani, M. Gupta, M. Andersen, S. Dhar, M. Fryknas, A. Isaksson, R. Larsson, and A.-C. Syvanen Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells Nucleic Acids Res., March 12, 2007; 35(5): e34 - e34. [Abstract] [Full Text] [PDF]

				E. G. Pearce, R. C. Laxton, A. C. Pereira, and S. Ye Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer Cells Mol. Cancer Res., March 1, 2007; 5(3): 221 - 227. [Abstract] [Full Text] [PDF]

				T. Sun, Y. Gao, W. Tan, S. Ma, X. Zhang, Y. Wang, Q. Zhang, Y. Guo, D. Zhao, C. Zeng, et al. Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression Clin. Cancer Res., December 1, 2006; 12(23): 7009 - 7017. [Abstract] [Full Text] [PDF]

				M. Sugimoto, S. Yoshida, S. Kennedy, M. Deguchi, N. Ohara, and T. Maruo Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms and Endometrial Carcinoma Risk in a Japanese Population Reproductive Sciences, October 1, 2006; 13(7): 523 - 529. [Abstract] [PDF]

				A. Flex, E. Gaetani, A. S. Proia, G. Pecorini, G. Straface, F. Biscetti, G. Fioroni, A. Sabusco, R. Flore, P. Tondi, et al. Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2006; 61(10): 1065 - 1069. [Abstract] [Full Text] [PDF]

				R. S. Heist, A. L. Marshall, G. Liu, W. Zhou, L. Su, D. Neuberg, T. J. Lynch, J. Wain, and D. C. Christiani Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer. Clin. Cancer Res., September 15, 2006; 12(18): 5448 - 5453. [Abstract] [Full Text] [PDF]

				K. K. Nelson, S. Subbaram, K. M. Connor, J. Dasgupta, X.-F. Ha, T.-C. Meng, N. K. Tonks, and J. A. Melendez Redox-dependent Matrix Metalloproteinase-1 Expression Is Regulated by JNK through Ets and AP-1 Promoter Motifs J. Biol. Chem., May 19, 2006; 281(20): 14100 - 14110. [Abstract] [Full Text] [PDF]

				L. Su, W. Zhou, K. Asomaning, X. Lin, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer Carcinogenesis, May 1, 2006; 27(5): 1024 - 1029. [Abstract] [Full Text] [PDF]

				N. Takemura, S. Yoshida, S. Kennedy, M. Deguchi, N. Ohara, and T. Maruo Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms Are Not Associated With an Increased Risk of Uterine Leiomyomas in a Japanese Population Reproductive Sciences, April 1, 2006; 13(3): 232 - 236. [Abstract] [PDF]

				A. G. Schwartz and J. C. Ruckdeschel Familial Lung Cancer: Genetic Susceptibility and Relationship to Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 16 - 22. [Abstract] [Full Text] [PDF]

				T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, et al. An Approach to Studying Lung Cancer-related Proteins in Human Blood Mol. Cell. Proteomics, October 1, 2005; 4(10): 1480 - 1486. [Abstract] [Full Text] [PDF]

				K. Shan, W. Ying, Z. Jian-Hui, G. Wei, W. Na, and L. Yan The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China Mol. Hum. Reprod., June 1, 2005; 11(6): 423 - 427. [Abstract] [Full Text] [PDF]

				Y. Zhou, C. Yu, X. Miao, Y. Wang, W. Tan, T. Sun, X. Zhang, P. Xiong, and D. Lin Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility Carcinogenesis, June 1, 2005; 26(6): 1117 - 1121. [Abstract] [Full Text] [PDF]

				L. Su, W. Zhou, S. Park, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani Matrix Metalloproteinase-1 Promoter Polymorphism and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 567 - 570. [Abstract] [Full Text] [PDF]

				M. B. Schabath, G. L. Delclos, M. M. Martynowicz, A. J. Greisinger, C. Lu, X. Wu, and M. R. Spitz Opposing Effects of Emphysema, Hay Fever, and Select Genetic Variants on Lung Cancer Risk Am. J. Epidemiol., March 1, 2005; 161(5): 412 - 422. [Abstract] [Full Text] [PDF]

				S. Fang, X. Jin, R. Wang, Y. Li, W. Guo, N. Wang, Y. Wang, D. Wen, L. Wei, and J. Zhang Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China Carcinogenesis, February 1, 2005; 26(2): 481 - 486. [Abstract] [Full Text] [PDF]

				F. Zinzindohoue, T. Lecomte, J.-M. Ferraz, A.-M. Houllier, P.-H. Cugnenc, A. Berger, H. Blons, and P. Laurent-Puig Prognostic Significance of MMP-1 and MMP-3 Functional Promoter Polymorphisms in Colorectal Cancer Clin. Cancer Res., January 15, 2005; 11(2): 594 - 599. [Abstract] [Full Text] [PDF]

				M. R. Spitz, X. Wu, and G. Mills Integrative Epidemiology: From Risk Assessment to Outcome Prediction J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275. [Abstract] [Full Text] [PDF]

				Y. Jia, Z.-Z. Zeng, S. M. Markwart, K. F. Rockwood, K. M. W. Ignatoski, S. P. Ethier, and D. L. Livant Integrin Fibronectin Receptors in Matrix Metalloproteinase-1-Dependent Invasion by Breast Cancer and Mammary Epithelial Cells Cancer Res., December 1, 2004; 64(23): 8674 - 8681. [Abstract] [Full Text] [PDF]

				H. Hirata, N. Okayama, K. Naito, R. Inoue, S. Yoshihiro, H. Matsuyama, Y. Suehiro, Y. Hamanaka, and Y. Hinoda Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma Carcinogenesis, December 1, 2004; 25(12): 2379 - 2384. [Abstract] [Full Text] [PDF]

				Y.-C. Fong, C. M. Dutton, S. S. Cha, N. Garamszegi, F. H. Sim, and S. P. Scully Absence of a Correlation between the Presence of a Single Nucleotide Polymorphism in the Matrix Metalloproteinase 1 Promoter and Outcome in Patients of Chondrosarcoma Clin. Cancer Res., November 1, 2004; 10(21): 7329 - 7334. [Abstract] [Full Text] [PDF]

				C. Yu, Y. Zhou, X. Miao, P. Xiong, W. Tan, and D. Lin Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer Cancer Res., October 15, 2004; 64(20): 7622 - 7628. [Abstract] [Full Text] [PDF]

				H. Blons, S. Gad, F. Zinzindohoue, I. Maniere, J. Beauregard, D. Tregouet, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig Matrix Metalloproteinase 3 Polymorphism: A Predictive Factor of Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., April 15, 2004; 10(8): 2594 - 2599. [Abstract] [Full Text] [PDF]

				J. Listgarten, S. Damaraju, B. Poulin, L. Cook, J. Dufour, A. Driga, J. Mackey, D. Wishart, R. Greiner, and B. Zanke Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms Clin. Cancer Res., April 15, 2004; 10(8): 2725 - 2737. [Abstract] [Full Text] [PDF]

				Y. Zhou, C. Yu, X. Miao, W. Tan, G. Liang, P. Xiong, T. Sun, and D. Lin Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes Carcinogenesis, March 1, 2004; 25(3): 399 - 404. [Abstract] [Full Text] [PDF]

				G. Ghilardi, M. L. Biondi, M. Erario, E. Guagnellini, and R. Scorza Colorectal Carcinoma Susceptibility and Metastases Are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms Clin. Chem., November 1, 2003; 49(11): 1940 - 1942. [Full Text] [PDF]

				R. M. Wenham, B. Calingaert, S. Ali, K. McClean, R. Whitaker, R. Bentley, J. M. Lancaster, J. Schildkraut, J. Marks, and A. Berchuck Matrix Metalloproteinase-1 Gene Promoter Polymorphism and Risk of Ovarian Cancer Reproductive Sciences, September 1, 2003; 10(6): 381 - 387. [Abstract] [PDF]

				X. Miao, C. Yu, W. Tan, P. Xiong, G. Liang, W. Lu, and D. Lin A Functional Polymorphism in the Matrix Metalloproteinase-2 Gene Promoter (-1306C/T) Is Associated with Risk of Development but not Metastasis of Gastric Cardia Adenocarcinoma Cancer Res., July 15, 2003; 63(14): 3987 - 3990. [Abstract] [Full Text] [PDF]

				N. L. Degg, M. M. Weil, A. Edwards, J. Haines, M. Coster, J. Moody, M. Ellender, R. Cox, and A. Silver Adenoma Multiplicity in Irradiated ApcMin Mice Is Modified by Chromosome 16 Segments from BALB/c Cancer Res., May 15, 2003; 63(10): 2361 - 2363. [Abstract] [Full Text] [PDF]

				F. Thibaud-Nissen, R. T. Shealy, A. Khanna, and L. O. Vodkin Clustering of Microarray Data Reveals Transcript Patterns Associated with Somatic Embryogenesis in Soybean Plant Physiology, May 1, 2003; 132(1): 118 - 136. [Abstract] [Full Text] [PDF]

				C. A. Wyatt, C. I. Coon, J. J. Gibson, and C. E. Brinckerhoff Potential for the 2G Single Nucleotide Polymorphism in the Promoter of Matrix Metalloproteinase to Enhance Gene Expression in Normal Stromal Cells Cancer Res., December 15, 2002; 62(24): 7200 - 7202. [Abstract] [Full Text] [PDF]

				G. Ghilardi, M. L. Biondi, M. Caputo, S. Leviti, M. DeMonti, E. Guagnellini, and R. Scorza A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-3 Promoter Enhances Breast Cancer Susceptibility Clin. Cancer Res., December 1, 2002; 8(12): 3820 - 3823. [Abstract] [Full Text] [PDF]

				C. Yu, K. Pan, D. Xing, G. Liang, W. Tan, L. Zhang, and D. Lin Correlation between a Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter and Risk of Lung Cancer Cancer Res., November 15, 2002; 62(22): 6430 - 6433. [Abstract] [Full Text] [PDF]